Filing Flows › Companies › Bio-Techne › Report card
Bio-Techne earnings report card
Every report on file against what analysts and the company itself expected, and what the stock did
Beat rate2 of 5 reports beat the EPS estimate
Bio-Techne (TECH) beat the analysts' EPS estimate in 2 of its last 5 reports (40%), by +0.6% on average. On report days the stock moved 4.8% in either direction on median (largest 10.2%), rising 50% of the time. Next report: Nov 9, 2026, analysts expect EPS $0.48; options imply a move of about ±1.6%.
Report by report
| Quarter | Reported | EPS est. | EPS reported | Surprise | GAAP EPS | Revenue reported | Stock, the day | vs market |
|---|---|---|---|---|---|---|---|---|
| Q1 FY27 | Nov 6, 2026 | $0.45 | $0.44 | -1.7% | $0.18 | $300M | — | — |
| Q4 FY26 | Aug 12, 2026 | $0.52 | $0.52 | +0.1% | — | $321M | +0.0% | -0.9% |
| Q3 FY26 | May 6, 2026 | $0.53 | $0.53 | -0.8% | $0.32 | $311M | -10.2% | -11.3% |
| Q2 FY26 | Feb 4, 2026 | $0.43 | $0.46 | +5.8% | $0.24 | $296M | +1.9% | +3.6% |
| Q1 FY26 | Nov 5, 2025 | $0.42 | $0.42 | -0.4% | $0.24 | $287M | -4.8% | -4.0% |
Estimates and reported EPS are the Street's adjusted figures; GAAP EPS is from the filing (SEC XBRL). Revenue reported is from the company's filing. The stock's move is close to close around the report date (the close before it to the close of the session after), against SPY for the market column.
Charts
The earnings-day move
Over 4 reports the stock moved 4.8% on median on the day (close to close), the largest move 10.2%.
For the next report the options price in about ±1.6% — less than the stock's median move (3.0× the implied); a range that size would have covered 25% of the past moves.
Read it as: the stock has often moved more than the options priced in.
The next report: what to expect → Bio-Techne: every quarter →
Read automatically from SEC filings, earnings releases and public estimates; errors are possible. Not investment advice.